We are live on
!
Find out more
Stifel Financial Portfolio holdings
AUM
$109B
1-Year Est. Return
21.36%
This Fund
S&P 500
This Quarter
Est. Return
+10.33%
1 Year Est. Return
+21.36%
3 Year Est. Return
+66.37%
5 Year Est. Return
+85.41%
10 Year Est. Return
+302.98%
AUM
$66.6B
AUM Growth
+$5.55B
(+9.1%)
Cap. Flow
+$370M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
14.79%
Holding
3,449
New
177
Increased
1,464
Reduced
1,530
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$362M |
| 2 |
Tractor Supply
TSCO
|
+$274M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.7M |
| 4 |
Biohaven
BHVN
|
+$79.4M |
| 5 |
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
|
+$76.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$464M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$363M |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$59.5M |
| 4 |
Duke Energy
DUK
|
+$58.5M |
| 5 |
Meta Platforms (Facebook)
META
|
+$53.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.39% |
| 2 | Healthcare | 12.41% |
| 3 | Industrials | 9.84% |
| 4 | Consumer Staples | 9.52% |
| 5 | Financials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLYM
3176
Climb Bio
CLYM
$719M
| $54.5K | ﹤0.01% |
14,862
-1,300
| -8% | -$3.86K |
|
3177
Energy Vault
NRGV
$591M
| $54.5K | ﹤0.01% |
17,469
+144
| +0.8% | +$534 |
|
|
RCS
3178
PIMCO Strategic Income Fund
RCS
$247M
| $52.4K | ﹤0.01% |
+10,607
| New | +$54.1K |
|
|
CHS
3179
DELISTED
Chicos FAS, Inc.
CHS
| $50.7K | ﹤0.01% |
10,300
+300
| +3% | +$1.69K |
|
3180
OptimumBank Holdings
OPHC
$110M
| $49.1K | ﹤0.01% |
12,000
| – | – |
|
3181
Purple Innovation
PRPL
$42.4M
| $47.9K | ﹤0.01% |
400
| – | – |
|
|
FIRY
3182
Firy Inc
FIRY
$146M
| $47.6K | ﹤0.01% |
4,703
-929
| -16% | -$17.1K |
|
|
OTLY
3183
Oatly Group
OTLY
$461M
| $46.3K | ﹤0.01% |
1,330
-685
| -34% | -$26.1K |
|
3184
Hyliion Holdings
HYLN
$729M
| $45.8K | ﹤0.01% |
19,562
-5,500
| -22% | -$14.9K |
|
|
NGD
3185
DELISTED
New Gold Inc
NGD
| $45.8K | ﹤0.01% |
46,687
-44,000
| -49% | -$44.3K |
|
3186
Playboy Inc
PLBY
$141M
| $45.6K | ﹤0.01% |
16,583
+174
| +1% | +$622 |
|
|
CGC
3187
Canopy Growth
CGC
$393M
| $45.3K | ﹤0.01% |
1,961
-248
| -11% | -$7.65K |
|
3188
UWM Holdings
UWMC
$661M
| $45.1K | ﹤0.01% |
13,612
-6,508
| -32% | -$24.4K |
|
3189
Quad
QUAD
$544M
| $44.9K | ﹤0.01% |
+11,000
| New | +$35K |
|
|
ADAP
3190
DELISTED
Adaptimmune Therapeutics
ADAP
| $44.8K | ﹤0.01% |
30,683
+1,150
| +4% | +$1.86K |
|
3191
Rekor Systems
REKR
$94.9M
| $44.8K | ﹤0.01% |
37,324
| – | – |
|
3192
Verrica Pharmaceuticals
VRCA
$92.9M
| $44.3K | ﹤0.01% |
+1,613
| New | +$43K |
|
3193
Kinross Gold
KGC
$28B
| $43.8K | ﹤0.01% |
+10,713
| New | +$42.4K |
|
3194
Energous
WATT
$98.2M
| $43.8K | ﹤0.01% |
87
-1
| -1% | -$603 |
|
3195
MiMedx Group
MDXG
$622M
| $43.1K | ﹤0.01% |
15,500
-1
| -0% | -$3 |
|
3196
Geron
GERN
$860M
| $41.1K | ﹤0.01% |
+17,000
| New | +$38.1K |
|
|
NKLA
3197
DELISTED
Nikola Corporation Common Stock
NKLA
| $41.1K | ﹤0.01% |
635
+114
| +22% | +$9.53K |
|
3198
Gevo
GEVO
$377M
| $40.5K | ﹤0.01% |
21,320
+20
| +0.1% | +$42 |
|
3199
Senseonics Holdings Inc
SENS
$282M
| $39.7K | ﹤0.01% |
1,926
-1,247
| -39% | -$28.8K |
|
3200
Cognyte Software
CGNT
$685M
| $39.6K | ﹤0.01% |
12,722
-7,776
| -38% | -$22.8K |
|
Similar funds
Stifel Financial's Q4 2022 Portfolio in Review
As of Q4 2022, Stifel Financial held 3,449 positions worth $66.6B, up 9.1% from $61.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Stifel Financial's Q4 2022 filing shows 177 new, 1,464 increased, 1,530 reduced and 165 closed positions. Its largest new stake was Biohaven: 5,619,760 shares worth $78M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $464M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Industrials.
- Stifel Financial's largest Q4 2022 buy was Biohaven: 5,619,760 shares worth $78M.
- Stifel Financial added most to iShares US Treasury Bond ETF in Q4 2022, an estimated $362M increase.
- Stifel Financial's biggest Q4 2022 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $363M.
- Stifel Financial fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $464M.
- Stifel Financial's ten largest holdings make up 15% of its $66.6B portfolio in Q4 2022.
- Stifel Financial opened 177 new positions and closed 165 in Q4 2022.
- Stifel Financial's portfolio value rose 9.1% quarter-over-quarter to $66.6B.
Based on Stifel Financial's 13F filing for Q4 2022, filed 13 Feb 2023.